Clinical Trial Update: Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial

View source ↗

Summary

A prospective pharmacogenetic study investigates how genetic factors influence warfarin dose-response. The trial is sponsored by Sheba Medical Center and target…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Cardiovascular Diseases | Status: UNKNOWN